Articles by Patrick Angelastro - Pharmaceutical Executive


Articles by Patrick Angelastro

Patrick Angelastro

Special Report: Platform Drugs—Marketing Your Opportunities
May 1, 2008

Tracking business by indication is critical for evaluating market performance and making accurate resource allocations

No Margin for Error
September 1, 2005

When rebate strategies are coupled with sales force and DTC spending, it results in "margin-negative" business—that is, sales that bring in less than the marginal cost of selling, promoting, and manufacturing the drug.


Click here